-
1
-
-
0027257511
-
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
-
Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993;95:315-328.
-
(1993)
Am J Med
, vol.95
, pp. 315-328
-
-
Landefeld, C.S.1
Beyth, R.J.2
-
2
-
-
0015498982
-
Mechanism of action of warfarin: Warfarin and metabolism of vitamin K1
-
Bell RG, Sadowski JA, Matschiner JT. Mechanism of action of warfarin: warfarin and metabolism of vitamin K1. Biochemistry. 1972;11:1959-1961.
-
(1972)
Biochemistry
, vol.11
, pp. 1959-1961
-
-
Bell, R.G.1
Sadowski, J.A.2
Matschiner, J.T.3
-
3
-
-
1142274548
-
Identification of the gene for vitamin K epoxide reductase
-
Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW. Identification of the gene for vitamin K epoxide reductase. Nature. 2004;427:541-544.
-
(2004)
Nature
, vol.427
, pp. 541-544
-
-
Li, T.1
Chang, C.Y.2
Jin, D.Y.3
Lin, P.J.4
Khvorova, A.5
Stafford, D.W.6
-
4
-
-
10744228888
-
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
-
Rost S, Fregin A, Ivaskevicius V, et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature. 2004;427:537-541.
-
(2004)
Nature
, vol.427
, pp. 537-541
-
-
Rost, S.1
Fregin, A.2
Ivaskevicius, V.3
-
5
-
-
0030970641
-
Genomic sequence and transcription start site for the human gamma-glutamyl carboxylase
-
Wu SM, Stafford DW, Frazier LD, et al. Genomic sequence and transcription start site for the human gamma-glutamyl carboxylase. Blood. 1997;89:4058-4062.
-
(1997)
Blood
, vol.89
, pp. 4058-4062
-
-
Wu, S.M.1
Stafford, D.W.2
Frazier, L.D.3
-
6
-
-
4143112300
-
Compound heterozygous mutations in the gamma-glutamyl carboxylase gene cause combined deficiency of all vitamin K-dependent blood coagulation factors
-
Rost S, Fregin A, Koch D, Compes M, Muller CR, Oldenburg J. Compound heterozygous mutations in the gamma-glutamyl carboxylase gene cause combined deficiency of all vitamin K-dependent blood coagulation factors. Br J Haematol. 2004;126:546-549.
-
(2004)
Br J Haematol
, vol.126
, pp. 546-549
-
-
Rost, S.1
Fregin, A.2
Koch, D.3
Compes, M.4
Muller, C.R.5
Oldenburg, J.6
-
7
-
-
0033916577
-
The vitamin K-dependent carboxylase
-
Berkner KL. The vitamin K-dependent carboxylase. J Nutr. 2000;130:1877-1880.
-
(2000)
J Nutr
, vol.130
, pp. 1877-1880
-
-
Berkner, K.L.1
-
8
-
-
1642335299
-
Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and gamma-glutamyl carboxylase) gene variants with warfarin sensitivity
-
Shikata E, Ieiri I, Ishiguro S, et al. Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and gamma-glutamyl carboxylase) gene variants with warfarin sensitivity. Blood. 2004;103:2630-2635.
-
(2004)
Blood
, vol.103
, pp. 2630-2635
-
-
Shikata, E.1
Ieiri, I.2
Ishiguro, S.3
-
9
-
-
1342332251
-
Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors
-
Wadelius M, Sörlin K, Wallerman O, et al. Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors. Pharmacogenomics J. 2004;4:40-48.
-
(2004)
Pharmacogenomics J
, vol.4
, pp. 40-48
-
-
Wadelius, M.1
Sörlin, K.2
Wallerman, O.3
-
10
-
-
23644437525
-
Common VKORC1 and GGCX polymorphisms associated with warfarin dose
-
Wadelius M, Chen LY, Downes K, et al. Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J. 2005;5:262-270.
-
(2005)
Pharmacogenomics J
, vol.5
, pp. 262-270
-
-
Wadelius, M.1
Chen, L.Y.2
Downes, K.3
|